| Differentiating BOLD and non-BOLD signals in fMRI time series using multi-echo EPI P Kundu, SJ Inati, JW Evans, WM Luh, PA Bandettini Neuroimage 60 (3), 1759-1770, 2012 | 723 | 2012 |
| ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing L Schmaal, E Pozzi, T C. Ho, LS Van Velzen, IM Veer, N Opel, ... Translational psychiatry 10 (1), 172, 2020 | 183 | 2020 |
| Neural correlates of personally familiar faces: parents, partner and own faces MJ Taylor, M Arsalidou, SJ Bayless, D Morris, JW Evans, EJ Barbeau Human brain mapping 30 (7), 2008-2020, 2009 | 169 | 2009 |
| Default mode connectivity in major depressive disorder measured up to 10 days after ketamine administration JW Evans, J Szczepanik, N Brutsché, LT Park, AC Nugent, CA Zarate Jr Biological psychiatry 84 (8), 582-590, 2018 | 160 | 2018 |
| The changing face of emotion: age-related patterns of amygdala activation to salient faces RM Todd, JW Evans, D Morris, MD Lewis, MJ Taylor Social cognitive and affective neuroscience 6 (1), 12-23, 2011 | 120 | 2011 |
| Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals A Mkrtchian, JW Evans, C Kraus, P Yuan, B Kadriu, AC Nugent, JP Roiser, ... Molecular psychiatry 26 (7), 3292-3301, 2021 | 91 | 2021 |
| Separating slow BOLD from non-BOLD baseline drifts using multi-echo fMRI JW Evans, P Kundu, SG Horovitz, PA Bandettini NeuroImage 105, 189-197, 2015 | 79 | 2015 |
| Ketamine normalizes brain activity during emotionally valenced attentional processing in depression JL Reed, AC Nugent, ML Furey, JE Szczepanik, JW Evans, CA Zarate Jr NeuroImage: Clinical 20, 92-101, 2018 | 71 | 2018 |
| A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression LT Park, B Kadriu, TD Gould, P Zanos, D Greenstein, JW Evans, P Yuan, ... International Journal of Neuropsychopharmacology 23 (7), 417-425, 2020 | 58 | 2020 |
| Effects of ketamine on brain activity during emotional processing: Differential findings in depressed versus healthy control participants JL Reed, AC Nugent, ML Furey, JE Szczepanik, JW Evans, CA Zarate Jr Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 4 (7), 610-618, 2019 | 54 | 2019 |
| Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment C Kraus, A Mkrtchian, B Kadriu, AC Nugent, CA Zarate Jr, JW Evans Neuropsychopharmacology 45 (6), 982-989, 2020 | 53 | 2020 |
| Brain correlates of suicide attempt in 18,925 participants across 18 international cohorts AI Campos, PM Thompson, DJ Veltman, E Pozzi, LS van Veltzen, ... Biological psychiatry 90 (4), 243-252, 2021 | 44 | 2021 |
| Multimodal imaging reveals a complex pattern of dysfunction in corticolimbic pathways in major depressive disorder AC Nugent, C Farmer, JW Evans, SL Snider, D Banerjee, CA Zarate Jr Human brain mapping 40 (13), 3940-3950, 2019 | 44 | 2019 |
| 7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study JW Evans, N Lally, L An, N Li, AC Nugent, D Banerjee, SL Snider, J Shen, ... Neuropsychopharmacology 43 (9), 1908-1914, 2018 | 43 | 2018 |
| Group specific optimisation of fMRI processing steps for child and adult data JW Evans, RM Todd, MJ Taylor, SC Strother Neuroimage 50 (2), 479-490, 2010 | 43 | 2010 |
| Mapping anticipatory anhedonia: an fMRI study JE Szczepanik, JL Reed, AC Nugent, ED Ballard, JW Evans, CW Lejuez, ... Brain imaging and behavior 13, 1624-1634, 2019 | 25 | 2019 |
| Withholding response in the face of a smile: age-related differences in prefrontal sensitivity to Nogo cues following happy and angry faces RM Todd, W Lee, JW Evans, MD Lewis, MJ Taylor Developmental cognitive neuroscience 2 (3), 340-350, 2012 | 25 | 2012 |
| Functional Imaging of the Implicit Association of the Self With Life and Death ED Ballard, JL Reed, J Szczepanik, JW Evans, JS Yarrington, ... Suicide and Life‐Threatening Behavior 49 (6), 1600-1608, 2019 | 19 | 2019 |
| The use of functional magnetic resonance imaging (fMRI) in clinical trials and experimental research studies for depression V Kotoula, JW Evans, CE Punturieri, CA Zarate Jr Frontiers in Neuroimaging 2, 2023 | 15 | 2023 |
| Functional MRI markers for treatment-resistant depression: Insights and challenges V Kotoula, JW Evans, C Punturieri, SC Johnson, CA Zarate Jr Progress in brain research 278, 117, 2023 | 12 | 2023 |
